Light Mode
$4.23 ↑ +0.03 (+0.71%) Trading Up from the previous close of $4.20, $0.58 below the day’s high of $4.81
-0.83 (-16.05%) / 6M
Momentum, market sentiment, and recent alerts
STLN reads not so good: the 12-month move is -16.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Starling Oncology, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.